🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 78402X107
- Market Cap
- Micro Cap · $76 Million
- Previous Symbol
- SCLRE (changed 5/18/2012)
Business: SCOLR, Inc., based in Bellevue, Washington, is a biopharmaceutical company leveraging specialized knowledge, proprietary and patented products and technologies, such as the patented CDT Controlled Delivery Technology platform, to introduce distinctive and novel OTC products, prescription drugs and dietary supplements. SCOLR's CDT drug delivery platform provides distinctive products with tangible benefits for the consumer and competitive commercial advantages for licensees. Partnerships with pharmaceutical, OTC and natural products industry companies will enable SCOLR to co-develop new products and to add value and protection to existing product franchises.
Notes: Jan. 13, 2011 -- SCOLR Pharma, Inc. (OTCQB: SCLR) today announced that its common stock is expecting to begin trading in the over-the counter (OTC) market beginning January 13, 2011 under the trading symbol 'SCLR'. The common stock is expected to be quoted on the OTC Bulletin Board and OTCQB™ Market on that date. SCOLR's common stock will cease trading on the NYSE Amex Exchange at the close of business on January 12, 2011.
Company Contact
- CEO
- Daniel O. Wilds
- CFO
- Steven H. Moger
- Headquarters
- 3625 132nd Avenue SE, Suite 300, Bellevue, WA 98006
- Phone
- 425-373-0171
- Fax
- 425-373-0181
- Investor Relations
- Terri MacInnis · 818-379-8500 · info@scolr.com